Jones Financial Companies
AMED

Jones Financial Companies’s Amedisys AMED Stock Holding History

Jones Financial Companies’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-173
Closed -$16.9K – 4232
2025
Q2 		$16.9K Buy
+173
New +$16.4K ﹤0.01% 2671
2025
Q1 		– Sell
-17
Closed -$1.54K – 3701
2024
Q4 		$1.54K Buy
17
+2
+13% +$184 ﹤0.01% 3059
2024
Q3 		$1.45K Hold
15
– – ﹤0.01% 2744
2024
Q2 		$1.38K Buy
+15
New +$1.39K ﹤0.01% 2232
2013
Q3 		– Sell
-487
Closed -$6K – 719
2013
Q2 		$6K Buy
+487
New +$5.58K ﹤0.01% 660

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Jones Financial Companies's AMED Position: Q3 2025 in Review

Jones Financial Companies sold out of Amedisys (AMED) in Q3 2025, closing a stake of 173 shares — an estimated $16.9K sold.

Jones Financial Companies first reported a position in AMED in Q2 2013 and held it in 5 quarters. The position peaked at $16.9K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Jones Financial Companies reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Jones Financial Companies sold 173 Amedisys shares in Q3 2025, an estimated $16.9K.
  • Jones Financial Companies first reported a position in Amedisys in Q2 2013 and held it in 5 quarters.
  • Jones Financial Companies's Amedisys position peaked at $16.9K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Jones Financial Companies's 13F filing for Q3 2025, filed 4 Nov 2025.